European Association for the Study of Obesity
Organisation
Named in competing interests
Integrating incretin-based therapies into comprehensive obesity care: an EASO position statement
Fees or honoraria, Board or leadership role, 3 Sept 2026
Sources: pubmed.ncbi.nlm.nih.gov
Papers
Obesity with low muscle strength linked to poorer daily function
European journal of clinical nutrition, 11 Oct 2026
Advantages and Critical Reappraisal of New Clinical Obesity Definition Proposed by Lancet Commission
Journal of obesity & metabolic syndrome, 8 Oct 2026
EASL-EASD-EASO Guidance for the Use of Resmetirom and Semaglutide as MASH-Targeted Therapy
Journal of hepatology, 29 Sept 2026
Integrating incretin-based therapies into comprehensive obesity care: an EASO position statement
The Lancet regional health. Europe, 14 Sept 2026
Clinical nutrition ESPEN, 9 Sept 2026
Diabetes/metabolism research and reviews, 7 Sept 2026
EASO's New Obesity Framework and Incident Type 2 Diabetes: A Prospective Cohort Study
Diabetes, obesity & metabolism, 17 Aug 2026
Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition, 6 Aug 2026
Nutrition and cancer, 8 Jul 2026
Obesity facts, 27 Nov 2025
Obesity facts, 23 Jun 2025
ADA Scientific Sessions 2025 abstract, 13 Jun 2025
Definition and Diagnostic Criteria for Sarcopenic Obesity: ESPEN and EASO Consensus Statement
Obesity facts, 23 Feb 2022
Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement
Clinical nutrition (Edinburgh, Scotland), 22 Feb 2022